Who Paid My Doc
Phase II/III in UC patients
Research payments
$40,648
Through program year 2020, $40,648 in research payments was reported against Phase II/III in UC patients, across 110 payments, paid by Boehringer Ingelheim RCV GmbH & Co KG.
- Paid by
- Boehringer Ingelheim RCV GmbH & Co KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $1,087 | 10 |
| 2019 | Research | $39,561 | 100 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Timothy Ritter Southlake, TX Named on 10 payments
- Jill Gaidos Richmond, VA Named on 7 payments
- Michael Georgetson Sayre, PA Named on 6 payments
- Philip Ginsburg Hamden, CT Named on 6 payments
- Jeffry Katz Cleveland, OH Named on 6 payments
- Heba Iskandar Atlanta, GA Named on 6 payments
- Jason Hou Houston, TX Named on 5 payments
- G Verne Galveston, TX Named on 5 payments
- Udayakumar Navaneethan Orlando, FL Named on 4 payments
- Andria Mushahwar Maitland, FL Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.